Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1] Letter uri icon

Overview

MeSH Major

  • Antimetabolites, Antineoplastic
  • Fluorouracil
  • Oxidoreductases
  • Oxidoreductases Acting on CH-CH Group Donors

publication date

  • November 15, 2001

Research

keywords

  • Letter

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2001.19.22.4267

PubMed ID

  • 11709571

Additional Document Info

start page

  • 4267

end page

  • 9

volume

  • 19

number

  • 22